supplements for glp-1 users Best to Take with Medications Rooted in Nature Backed by Science GLP-1 SOS™ Digestive Support for

Liraglutide has more years of post-market safety data (since 2010), but tirzepatide clinical trials involved large patient populations with rigorous safety monitoring

NAD is also a substrate for cellular signalling enzymes (sirtuins) and DNA repair enzymes (PARPs)

This dual modulation likely explains the neuroprotective effects in animal models and the neuropsychiatric side effects some users report at higher doses

Kutlu MD, Kose S, Akillioglu K

According to KFF analysis of Centers for Medicare & Medicaid Services 2018-2022 Medicare Part D spending by drug increased from $57 Million to $5.7 Billion.[2] The June 13, 2024 article in Fierce Healthcare[3] on GLP-1 drugs noted that Blue Cross Blue Shield of Michigan will no longer cover these drugs starting in January 2025, and will be changing the prior authorization criteria starting in August 2024, for those members that are in large group fully insured commercial plans